Markets

DENTSPLY (XRAY) Q4 Earnings Top Estimates, Sales Up Y/Y

DENTSPLY SIRONA IncXRAY is one of the leading worldwide manufacturers' dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.

Currently, this York, PA- based company carries a Zacks Rank #4 (Sell) but that could change following its fourth quarter 2016 earnings report which has just released. (You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.) We have highlighted some of the key details from the just-released announcement below:

Earnings: DENTSPLY reported adjusted earnings of 67 cents per share, which beat the Zacks Consensus Estimate by 2 cents and was higher than earnings of 65 cents in the year-ago quarter.

DENTSPLY SIRONA Inc. Price and EPS Surprise

DENTSPLY SIRONA Inc. Price and EPS Surprise | DENTSPLY SIRONA Inc. Quote

Revenues: DENTSPLY's net sales increased to $996.5 million from $671.1 million in the year-ago period. However this came below the Zacks Consensus Estimate of $1,019.0 million. Sales of the combined businesses grew 4.3% at constant currency (cc) exchange rates.

Key Stats: Dental and Healthcare Consumables sales rose 3.4% year over year at cc, while Technologies grew 5.2% in the quarter.

Major Factors: U.S. business in the fourth quarter was negatively impacted by channel inventory reduction related to a change in distribution strategy in North America. The company expects adjusted EPS for full year 2017 in the range of $2.80 to $2.90 per diluted share.

Stock Price: Shares have risen 6.88% over the past one month, while the Zacks categorized Medical - Dental Supplies sub industry has gained roughly 2.78% over the same time frame.

Check back later for our full write up on this DENTSPLY earnings report later!

Just Released - Driverless Cars: Your Roadmap to Mega-Profits Today

In this latest Special Report, Zacks' Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making - autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

XRAY

Other Topics

Earnings Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More